ARCHIVES

Genentech: ODAC Lacks Expertise, Impartiality; FDA: Company’s Proposal Unscientific

This article is from The Cancer Letter archive.

Vol. 37 No. 32 | August 12, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Committee Approves Two NDAs, Blocks One, Hears NCI Toxicology Plan

June 15, 1979

NCI To Fund Study of Stomach Cancer In Poles, Polish Americans, In Warsaw And Chicago Areas

April 17, 1992

Obituaries: Eleanor Nealson, 59, NCI Liaison to Patients, Formed consumer Advisory Group

October 29, 1999

ODAC Okays Photofrin for Obstructive Esophageal Cancer

September 23, 1994

New Biomedical Research Panel Accepts Broad Mandate. May Suggest Separate Health Dept.

February 28, 1975

An Early Look At How NCI Plans To Spend Its Money In 1980

July 7, 1978